回复对“进行性纤维性间质性肺疾病的自然史”的评论。
Reply to comment on "The natural history of progressive fibrosing interstitial lung diseases".
机构信息
Dept of Medicine, National Jewish Health, Denver, CO, USA
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA.
出版信息
Eur Respir J. 2020 Dec 17;56(6). doi: 10.1183/13993003.03967-2020. Print 2020 Dec.
Abstract
摘要
相似文献
1
Reply to comment on "The natural history of progressive fibrosing interstitial lung diseases".回复对“进行性纤维性间质性肺疾病的自然史”的评论。
Eur Respir J. 2020 Dec 17;56(6). doi: 10.1183/13993003.03967-2020. Print 2020 Dec.
2
Comment on "The natural history of progressive fibrosing interstitial lung diseases".关于《进行性纤维化间质性肺疾病的自然史》的评论
Eur Respir J. 2020 Dec 17;56(6). doi: 10.1183/13993003.03508-2020. Print 2020 Dec.
3
HRCT of fibrosing lung disease.纤维化性肺病的高分辨率计算机断层扫描
Respirology. 2015 Aug;20(6):859-72. doi: 10.1111/resp.12531. Epub 2015 Apr 21.
4
Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities.进行性纤维性间质性肺病：临床不确定性、共识建议和研究重点。
Lancet Respir Med. 2020 Sep;8(9):925-934. doi: 10.1016/S2213-2600(20)30355-6.
5
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. Reply.尼达尼布用于进行性纤维化间质性肺疾病。回复。
N Engl J Med. 2020 Feb 20;382(8):781. doi: 10.1056/NEJMc1917224.
6
Progressive Fibrosing Interstitial Lung Disease. A Proposed Integrated Algorithm for Management.进行性纤维化间质性肺疾病。一种提议的综合管理算法。
Ann Am Thorac Soc. 2020 Oct;17(10):1199-1203. doi: 10.1513/AnnalsATS.202003-214PS.
7
Progressive fibrosing interstitial lung disease: we know it behaves badly, but what does that mean?进行性纤维化间质性肺疾病：我们知道它的表现很糟糕，但这意味着什么呢？
Eur Respir J. 2020 Jun 25;55(6). doi: 10.1183/13993003.00894-2020. Print 2020 Jun.
8
Diagnosis of usual interstitial pneumonia and distinction from other fibrosing interstitial lung diseases.普通型间质性肺炎的诊断及与其他纤维化间质性肺疾病的鉴别。
Hum Pathol. 2008 Sep;39(9):1275-94. doi: 10.1016/j.humpath.2008.05.009.
9
June Podcast: The natural history of progressive fibrosing ILD.6月播客：进行性纤维化间质性肺疾病的自然史
Eur Respir J. 2020 Jul 7;55(6). doi: 10.1183/13993003.E5506-2020. Print 2020 Jun.
10
Erratum to "Diagnosis of usual interstitial pneumonia and distinction from other fibrosing interstitial lung diseases" [Hum Pathol 39 (2008) 1275-1294].《普通型间质性肺炎的诊断及与其他纤维化性间质性肺疾病的鉴别》[《人类病理学》39卷（2008年）1275 - 1294页]勘误
Hum Pathol. 2008 Nov;39(11):1562-81. doi: 10.1016/j.humpath.2008.09.001.
引用本文的文献
1
Epidemiology and Prognosis of Progressive Pulmonary Fibrosis: A Literature Review.进行性肺纤维化的流行病学与预后：文献综述
Pulm Ther. 2025 Jun 16. doi: 10.1007/s41030-025-00302-5.
2
Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry.特发性肺纤维化（IPF）或非特发性间质性肺炎患者的生存和急性加重：前瞻性多机构患者登记的 5 年随访分析。
BMJ Open Respir Res. 2023 Nov;10(1). doi: 10.1136/bmjresp-2023-001864.
本文引用的文献
1
The natural history of progressive fibrosing interstitial lung diseases.特发性肺纤维化等进行性纤维性间质性肺疾病的自然史。
Eur Respir J. 2020 Jun 25;55(6). doi: 10.1183/13993003.00085-2020. Print 2020 Jun.
Zotero 插件